Literature DB >> 11754517

Traumatic brain injury: developmental differences in glutamate receptor response and the impact on treatment.

P M Lea1, A I Faden.   

Abstract

Perinatal brain injury following trauma, hypoxia, and/or ischemia represents a substantial cause of pediatric disabilities including mental retardation. Such injuries lead to neuronal cell death through either necrosis or apoptosis. Numerous in vivo and in vitro studies implicate ionotropic (iGluRs) and metabotropic (mGluRs) glutamate receptors in the modulation of such cell death. Expression of glutamate receptors changes as a function of developmental age, with substantial implications for understanding mechanisms of post-injury cell death and its potential treatment. Recent findings suggest that the developing brain is more susceptible to apoptosis after injury and that such caspase mediated cell death may be exacerbated by treatment with N-methyl-D-aspartate receptor antagonists. Moreover, group I metabotropic glutamate receptors appear to have opposite effects on necrotic and apoptotic cell death. Understanding the relative roles of glutamate receptors in post-traumatic or post-ischemic cell death as a function of developmental age may lead to novel targeted approaches to the treatment of pediatric brain injury. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11754517     DOI: 10.1002/mrdd.1033

Source DB:  PubMed          Journal:  Ment Retard Dev Disabil Res Rev        ISSN: 1080-4013


  8 in total

1.  Infant mice with glutaric acidaemia type I have increased vulnerability to 3-nitropropionic acid toxicity.

Authors:  K B Bjugstad; L S Crnic; S I Goodman; C R Freed
Journal:  J Inherit Metab Dis       Date:  2006-08-30       Impact factor: 4.982

Review 2.  Multifunctional drugs for head injury.

Authors:  Robert Vink; Alan J Nimmo
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

3.  Glial cell responses in a murine multifactorial perinatal brain injury model.

Authors:  Miriam Domowicz; Natasha L Wadlington; Judith G Henry; Kasandra Diaz; Miranda J Munoz; Nancy B Schwartz
Journal:  Brain Res       Date:  2017-12-21       Impact factor: 3.252

4.  Astrocyte precursor response to embryonic brain injury.

Authors:  Miriam S Domowicz; Judith G Henry; Natasha Wadlington; Antonia Navarro; Richard P Kraig; Nancy B Schwartz
Journal:  Brain Res       Date:  2011-03-09       Impact factor: 3.252

Review 5.  Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species.

Authors:  Bridgette D Semple; Klas Blomgren; Kayleen Gimlin; Donna M Ferriero; Linda J Noble-Haeusslein
Journal:  Prog Neurobiol       Date:  2013-04-11       Impact factor: 11.685

6.  The AMPAR Antagonist Perampanel Attenuates Traumatic Brain Injury Through Anti-Oxidative and Anti-Inflammatory Activity.

Authors:  Tao Chen; Shu-Hui Dai; Zhi-Quan Jiang; Peng Luo; Xiao-Fan Jiang; Zhou Fei; Song-Bai Gui; Yi-Long Qi
Journal:  Cell Mol Neurobiol       Date:  2016-02-16       Impact factor: 5.046

7.  Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α.

Authors:  Lital Rachmany; David Tweedie; Vardit Rubovitch; Qian-Sheng Yu; Yazhou Li; Jia-Yi Wang; Chaim G Pick; Nigel H Greig
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 8.  Improved fracture healing in patients with concomitant traumatic brain injury: proven or not?

Authors:  Martijn Hofman; Guido Koopmans; Philipp Kobbe; Martijn Poeze; Hagen Andruszkow; Peter R G Brink; Hans-Christoph Pape
Journal:  Mediators Inflamm       Date:  2015-03-22       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.